Infantile Fibrosarcoma

Infantile Fibrosarcoma is a rare malignant soft tissue tumor primarily affecting infants and young children. This article provides an overview of this condition, its symptoms, and the available treatment approaches.

Infantile Fibrosarcoma

Key Takeaways

  • Infantile Fibrosarcoma is a rare soft tissue cancer predominantly found in infants, often present at birth or developing shortly thereafter.
  • The most common symptom is a rapidly growing, firm, and often painless mass, frequently located on the extremities, trunk, or head and neck.
  • Diagnosis involves imaging studies, biopsy, and molecular testing to confirm the characteristic genetic translocation.
  • Treatment typically involves surgical removal of the tumor, often supplemented with chemotherapy, especially for larger or unresectable tumors.
  • The infantile fibrosarcoma prognosis is generally favorable, particularly with complete surgical resection, though recurrence is possible.

What is Infantile Fibrosarcoma?

Infantile Fibrosarcoma refers to a rare type of cancer that originates in the soft tissues of infants, usually diagnosed within the first two years of life, and often present at birth (congenital). Unlike fibrosarcoma in adults, the infantile form tends to have a more favorable prognosis. It is characterized by specific genetic alterations, most commonly a translocation involving the ETV6-NTRK3 fusion gene, which plays a crucial role in its development and distinguishes it from other sarcomas.

This tumor can develop in various parts of the body, including the extremities, trunk, and head and neck region. While it can grow rapidly, it generally has a low metastatic potential compared to many other pediatric cancers. Its rarity means it accounts for a very small percentage of all pediatric soft tissue sarcomas, with incidence rates estimated to be less than one case per million children per year globally, as reported by various pediatric oncology registries.

Recognizing Infantile Fibrosarcoma Symptoms

Recognizing infantile fibrosarcoma symptoms is crucial for early diagnosis and intervention. The most common presentation is the appearance of a mass that can be felt or seen. These masses are typically:

  • Firm and palpable: The tumor often feels solid to the touch.
  • Rapidly growing: Parents or caregivers may notice a quick increase in the size of the mass over weeks or months.
  • Painless: In most cases, the mass does not cause pain to the infant, which can sometimes delay diagnosis.
  • Located on extremities: A significant number of tumors are found on the arms or legs, but they can also occur on the trunk, head, or neck.

Depending on the tumor’s location and size, it may also cause other issues, such as restricted movement if it’s near a joint, or pressure symptoms if it’s pressing on nerves or blood vessels. Any new or growing mass in an infant should prompt immediate medical evaluation to determine its nature.

Infantile Fibrosarcoma Treatment Options and Prognosis

The primary goal of managing Infantile Fibrosarcoma is complete removal of the tumor while preserving function. Infantile fibrosarcoma treatment options are typically tailored to the individual child, considering the tumor’s size, location, and whether it has spread. The cornerstone of treatment is surgical resection. For tumors that are small and easily accessible, surgery alone may be curative. However, for larger tumors or those in challenging locations, a multidisciplinary approach is often necessary.

Chemotherapy, often using agents like vincristine and dactinomycin, may be administered before surgery (neoadjuvant chemotherapy) to shrink the tumor and make it more resectable, or after surgery (adjuvant chemotherapy) to eliminate any remaining microscopic disease. Radiation therapy is generally avoided in very young children due to potential long-term side effects on growth and development, but it may be considered in specific, high-risk situations. The infantile fibrosarcoma prognosis is generally favorable, with high survival rates, especially when complete surgical removal is achieved. However, there is a risk of local recurrence, necessitating close follow-up with regular imaging and clinical examinations. Long-term monitoring is essential to detect any recurrence early and manage potential late effects of treatment.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.